Skip to main content

Advertisement

SpringerLink
Log in

Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer

  • Letter to the editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Au WW, Navasumrit P, Ruchirawat M (2004) Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health 207:301–313. doi:10.1078/1438-4639-00294

    Article  PubMed  CAS  Google Scholar 

  2. Abdel-Rahman SZ, El-Zein RA (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159:63–71. doi:10.1016/S0304-3835(00)00532-2

    Article  PubMed  CAS  Google Scholar 

  3. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC, Kelsey KT (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21:965–971. doi:10.1093/carcin/21.5.965

    Article  PubMed  CAS  Google Scholar 

  4. Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP (2004) Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 104:3872–3877. doi:10.1182/blood-2004-06-2161

    Article  PubMed  CAS  Google Scholar 

  5. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier Dietrich, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P et al (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11:4802–4809. doi:10.1158/1078-0432.CCR-04-2657

    Article  PubMed  CAS  Google Scholar 

  6. Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10:4939–4943. doi:10.1158/1078-0432.CCR-04-0247

    Article  PubMed  CAS  Google Scholar 

  7. Bewick MA, Conlon MS, Lafrenie RM (2006) Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 24:5645–5651. doi:10.1200/JCO.2006.05.9923

    Article  PubMed  CAS  Google Scholar 

  8. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H (2002) Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 23:1003–1008. doi:10.1093/carcin/23.6.1003

    Article  PubMed  CAS  Google Scholar 

  9. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J (2006) XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66:2860–2868. doi:10.1158/0008-5472.CAN-05-3388

    Article  PubMed  CAS  Google Scholar 

  10. Kiuru A, Lindholm C, Heilimo I, Ceppi M, Koivistoinen A, Ilus T, Hirvonen A, Norppa H, Salomaa S (2005) Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ Mol Mutagen 46:198–205. doi:10.1002/em.20155

    Article  PubMed  CAS  Google Scholar 

  11. Takanami T, Nakamura J, Kubota Y, Horiuchi S (2005) The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat Res 582:135–145

    PubMed  CAS  Google Scholar 

  12. Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22:2594–2601. doi:10.1200/JCO.2004.08.067

    Article  PubMed  CAS  Google Scholar 

  13. Yarosh DB, Pena A, Brown DA (2005) DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute Human Tumour Cell Line Screening Panel. Biomarkers 10:188–202. doi:10.1080/13547500500138732

    Article  PubMed  CAS  Google Scholar 

  14. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59:2557–2561

    PubMed  CAS  Google Scholar 

  15. Leng S, Cheng J, Zhang L, Niu Y, Dai Y, Pan Z, Li B, He F, Zheng Y (2005) The association of XRCC1 haplotypes and chromosomal damage levels in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol Biomarkers Prev 14:1295–1301. doi:10.1158/1055-9965.EPI-04-0690

    Article  PubMed  CAS  Google Scholar 

  16. Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M et al (2006) Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24:3789–3798. doi:10.1200/JCO.2005.03.6640

    Article  PubMed  CAS  Google Scholar 

  17. Liu B, Wei J, Zou Z, Qian X, Nakamura T, Zhang W, Ding Y, Feng J, Yu L (2007) Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population. Eur J Hum Genet 15:1049–1053. doi:10.1038/sj.ejhg.5201884

    Article  PubMed  CAS  Google Scholar 

  18. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R (2008) Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 134(6):645–652

    Article  PubMed  CAS  Google Scholar 

  19. Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, Park D, Lenz HJ (2001) A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 21:3075–3079

    PubMed  CAS  Google Scholar 

  20. Chung HH, Kim MK, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2006) XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. Gynecol Oncol 103:1031–1037. doi:10.1016/j.ygyno.2006.06.016

    Article  PubMed  CAS  Google Scholar 

  21. Mittal RD, Singh R, Manchanda PK, Ahirwar D, Gangwar R, Kesarwani P, Mandhani A (2008) XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biol Ther 7:645–650

    PubMed  CAS  Google Scholar 

  22. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989. doi:10.1086/319501

    Article  PubMed  CAS  Google Scholar 

  23. Tregouet DA, Garelle V (2007) A new JAVA interface implementation of thesias: testing haplotype effects in association studies. Bioinformatics 23:1038–1039. doi:10.1093/bioinformatics/btm058

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sudbury Regional Hospital, Regional Cancer Center, 41 Ramsey Lake Rd, Sudbury, ON, P3E 5J1, Canada

    Mary A. Bewick, Michael S. C. Conlon & Robert M. Lafrenie

  2. Northern Ontario School of Medicine, Sudbury, ON, Canada

    Robert M. Lafrenie

Authors
  1. Mary A. Bewick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S. C. Conlon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert M. Lafrenie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary A. Bewick.

Additional information

This work was supported by the Northern Cancer Research Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bewick, M.A., Conlon, M.S.C. & Lafrenie, R.M. Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer. Breast Cancer Res Treat 117, 667–669 (2009). https://doi.org/10.1007/s10549-008-0293-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-008-0293-x

Keywords

Search

Navigation